相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Signal transducer and activator of transcription 3 signaling in tumor immune evasion
Luying Zhang et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Profiling of immune features to predict immunotherapy efficacy
Youqiong Ye et al.
INNOVATION (2022)
STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
Alessandro Di Federico et al.
EUROPEAN JOURNAL OF CANCER (2021)
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
Phuong H. D. Nguyen et al.
NATURE COMMUNICATIONS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy
Oliver Klein et al.
CANCER CELL (2021)
STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications
Nithya Krishnamurthy et al.
EUROPEAN JOURNAL OF CANCER (2021)
Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker
Elena Fountzilas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
Fengying Wu et al.
NATURE COMMUNICATIONS (2021)
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
Hitoshi Dejima et al.
NATURE COMMUNICATIONS (2021)
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy
Giulia Mazzaschi et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
Artificial intelligence: A powerful paradigm for scientific research
Yongjun Xu et al.
INNOVATION (2021)
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
Tianzhi Wu et al.
INNOVATION (2021)
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Yu-Pei Chen et al.
CELL RESEARCH (2020)
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
Shogo Kumagai et al.
IMMUNITY (2020)
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden
D. Marinelli et al.
ANNALS OF ONCOLOGY (2020)
Single-Cell Multiomics Sequencing Reveals Prevalent Genomic Alterations in Tumor Stromal Cells of Human Colorectal Cancer
Yuan Zhou et al.
CANCER CELL (2020)
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
Hao Sun et al.
EBIOMEDICINE (2020)
RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
Chang Gu et al.
INNOVATION (2020)
Immune modulatory effects of oncogenic KRAS in cancer
Shaima'a Hamarsheh et al.
NATURE COMMUNICATIONS (2020)
Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
Zhihao Lu et al.
INNOVATION (2020)
Overcoming Resistance to Drugs Targeting KRASG12C Mutation
Delong Jiao et al.
INNOVATION (2020)
STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Simon Papillon-Cavanagh et al.
ESMO OPEN (2020)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD-L1 immunotherapy
Chih-Hsun Wu et al.
CANCER MEDICINE (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
Lawrence P. Andrews et al.
NATURE IMMUNOLOGY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Immune Cell Composition in Human Non-small Cell Lung Cancer
Branislava Stankovic et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer transcriptome profiling at the juncture of clinical translation
Marcin Cieslik et al.
NATURE REVIEWS GENETICS (2018)
Targeting the microenvironment in solid tumors
Carmen Belli et al.
CANCER TREATMENT REVIEWS (2018)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia et al.
NATURE COMMUNICATIONS (2018)
Programmed cell death ligand-1 (PD-L1) as a biomarker for non-small cell lung cancer (NSCLC) treatment-are we barking up the wrong tree?
Wolfram C. M. Dempke et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer A Meta-Analysis
Chee Khoon Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin et al.
CELL (2017)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The tumor microenvironment controls drug sensitivity
Arne Ostman
NATURE MEDICINE (2012)
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
Gunter P. Wagner et al.
THEORY IN BIOSCIENCES (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai et al.
CANCER (2008)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
